Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA's Second Rejection of Mannkind's Inhaled Insulin Has Investors Worried
FDA's Second Rejection of Mannkind's Inhaled Insulin Has Investors Worried
FDA's Second Rejection of Mannkind's Inhaled Insulin Has Investors Worried
Submitted by
admin
on January 20, 2011 - 10:11am
Source:
Seeking Alpha
News Tags:
FDA
inhaled insulin
MannKind
diabetes
Headline:
FDA's Second Rejection of Mannkind's Inhaled Insulin Has Investors Worried
Do Not Allow Advertisers to Use My Personal information
